Skip to main content

Kepler Capital Sticks to Its Hold Rating for Sanofi (SNYNF)

Tipranks - Tipranks - Thu Feb 5, 8:18PM CST

In a report released on February 3, Nicolas Pauillac from Kepler Capital maintained a Hold rating on Sanofi, with a price target of €85.00. The company’s shares closed last Monday at €81.08.

Claim 50% Off TipRanks Premium

According to TipRanks, Pauillac is a 5-star analyst with an average return of 18.2% and a 58.15% success rate. Pauillac covers the Healthcare sector, focusing on stocks such as Formycon AG, Eckert & Ziegler Strahlen und Medizintechnik, and Sanofi.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sanofi with a €96.56 average price target, a 19.09% upside from current levels. In a report released on January 30, Goldman Sachs also maintained a Hold rating on the stock with a €89.00 price target.

See the top stocks recommended by analysts >>

The company has a one-year high of €110.88 and a one-year low of €76.15. Currently, Sanofi has an average volume of 1.89M.

Read More on SNYNF:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).